Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,056,670    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $64,995,519      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 12 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-19 4 OE $14.39 $14,390 D/D 1,000 336,338 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-25 4 OE $14.39 $57,560 D/D 4,000 327,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-27 4 OE $14.39 $14,390 D/D 1,000 324,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-05 4 OE $14.39 $43,170 D/D 3,000 327,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-08 4 OE $14.39 $43,170 D/D 3,000 327,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-11 4 OE $14.39 $14,390 D/D 1,000 325,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-12 4 OE $14.39 $57,560 D/D 4,000 329,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-26 4 OE $14.39 $43,170 D/D 3,000 329,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-08 4 OE $14.39 $57,560 D/D 4,000 330,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-09 4 OE $14.39 $57,560 D/D 4,000 330,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-10 4 OE $14.39 $143,900 D/D 10,000 336,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2006-07-03 4 AB $14.44 $21,660 D/D 1,500 29,381 2.81 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2006-08-01 4 AB $14.50 $21,750 D/D 1,500 30,881 2.81 -
PTLA Portola Pharmaceuticals I... Director   –       •      –    2013-05-22 4 B $14.50 $29,000 D/D 2,000 2,000 2.39 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2009-06-12 4 B $14.52 $21,780 D/D 1,500 51,940 2.81 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2009-08-10 4 S $15.69 $31,889 D/D (2,000) 55,440 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2009-08-07 4 S $15.95 $31,902 D/D (2,000) 57,440 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-05-02 4 AS $16.36 $24,647 D/D (1,500) 15,142 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-03-02 4 AS $16.44 $24,723 D/D (1,500) 18,142 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-05-03 4 AS $16.70 $251,807 D/D (15,000) 17,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-02-20 4 AS $16.96 $220,481 D/D (13,000) 20,642 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-12-08 4 S $17.00 $67,988 D/D (4,000) 10,917 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-12-08 4 B $17.20 $68,792 D/D 4,000 14,917 2.81 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-15 4 OE $17.33 $737,859 D/D 42,577 421,161 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-12-29 4 OE $17.33 $69,320 D/D 4,000 174,682 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12  13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 12 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us